Annals of Oncology

1

Should we optimize cytotoxic therapy by dosing to neutropenia? Lessons from TAS-102

Kasi, P.M., Grothey, A.

Journal:

Annals of Oncology

Year:

2020

File:

PDF, 247 KB

2020

2

Differential effects of an electronic symptom monitoring intervention based on the age of patients with advanced cancer

Nipp, R.D., Horick, N.K., Deal, A.M., Rogak, L.J., Fuh, C., Greer, J.A., Dueck, A.C., Basch, E., Temel, J.S., El-Jawahri, A.

Journal:

Annals of Oncology

Year:

2020

File:

PDF, 301 KB

2020

3

Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma

Ugurel, S., Schadendorf, D., Horny, K., Sucker, A., Schramm, S., Utikal, J., Pföhler, C., Herbst, R., Schilling, B., Blank, C., Becker, J.C., Paschen, A., Zimmer, L., Livingstone, E., Horn, P.A., Rebm

Journal:

Annals of Oncology

Year:

2020

File:

PDF, 440 KB

2020

4

Relation of cetuximab-induced skin toxicity and early tumor shrinkage in metastatic colorectal cancer patients: results of the randomized phase 3 trial FIRE-3 (AIO KRK0306)

Holch, J.W., Held, S., Stintzing, S., Fischer von Weikersthal, L., Decker, T., Kiani, A., Kaiser, F., Heintges, T., Kahl, C., Kullmann, F., Scheithauer, W., Moehler, M., von Einem, J.C., Michl, M., He

Journal:

Annals of Oncology

Year:

2020

File:

PDF, 321 KB

2020

5

Man against machine reloaded: performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions

Haenssle, H.A., Fink, C., Toberer, F., Winkler, J., Stolz, W., Deinlein, T., Hofmann-Wellenhof, R., Lallas, A., Emmert, S., Buhl, T., Zutt, M., Blum, A., Abassi, M.S., Thomas, L., Tromme, I., Tschandl

Journal:

Annals of Oncology

Year:

2020

File:

PDF, 886 KB

2020

6

Transferring effective interventions for cancer-related fatigue from the adjuvant to the advanced cancer session: does it work?

May, A.M.

Journal:

Annals of Oncology

Year:

2020

File:

PDF, 142 KB

2020

7

Cognitive behavioral therapy or graded exercise therapy compared with usual care for severe fatigue in patients with advanced cancer during treatment: a randomized controlled trial

Poort, H., Peters, M.E.W.J., van der Graaf, W.T.A., Nieuwkerk, P.T., van de Wouw, A.J., Nijhuis-van der Sanden, M.W.G., Bleijenberg, G., Verhagen, C.A.H.H.V.M., Knoop, H.

Journal:

Annals of Oncology

Year:

2020

Language:

english

File:

PDF, 321 KB

english, 2020

8

Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)

Kundranda, M., Gracian, A.C., Zafar, S.F., Meiri, E., Bendell, J., Algül, H., Rivera, F., Ahn, E.R., Watkins, D., Pelzer, U., Charu, V., Zalutskaya, A., Kuesters, G., Pipas, J.M., Santillana, S., Asko

Journal:

Annals of Oncology

Year:

2020

Language:

english

File:

PDF, 386 KB

english, 2020

9

Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathy

Beijers, A.J.M., Bonhof, C.S., Mols, F., Ophorst, J., de Vos-Geelen, J., Jacobs, E.M.G., van de Poll-Franse, L.V., Vreugdenhil, G.

Journal:

Annals of Oncology

Year:

2020

Language:

english

File:

PDF, 254 KB

english, 2020

10

Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: risk and mortality in The Pooling Project of Prospective Studies of Diet and Cancer

Genkinger, J.M., Wu, K., Wang, M., Albanes, D., Black, A., van den Brandt, P.A., Burke, K.A., Cook, M.B., Gapstur, S.M., Giles, G.G., Giovannucci, E., Goodman, G.G., Goodman, P.J., Håkansson, N., Key,

Journal:

Annals of Oncology

Year:

2020

Language:

english

File:

PDF, 392 KB

english, 2020

11

Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAFv600 mutation–positive melanoma receiving adjuvant vemurafenib

Ascierto, P.A., Lewis, K.D., Di Giacomo, A.M., Demidov, L., Mandalà, M., Bondarenko, I., Herbert, C., Mackiewicz, A., Rutkowski, P., Guminski, A., Simmons, B., Ye, C., Hooper, G., Wongchenko, M.J., Go

Journal:

Annals of Oncology

Year:

2020

Language:

english

File:

PDF, 400 KB

english, 2020

12

Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer

De Ruysscher, D., Faivre-Finn, C., Nackaerts, K., Jordan, K., Arends, J., Douillard, J.Y., Ricardi, U., Peters, S.

Journal:

Annals of Oncology

Year:

2020

Language:

english

File:

PDF, 370 KB

english, 2020

13

Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials

Yoshino, T., Cleary, J.M., Van Cutsem, E., Mayer, R.J., Ohtsu, A., Shinozaki, E., Falcone, A., Yamazaki, K., Nishina, T., Garcia-Carbonero, R., Komatsu, Y., Baba, H., Argilés, G., Tsuji, A., Sobrero,

Journal:

Annals of Oncology

Year:

2020

Language:

english

File:

PDF, 457 KB

english, 2020

14

Financial toxicity in lung cancer: an assessment of magnitude, perception, and impact on quality of life

Hazell, S.Z., Fu, W., Hu, C., Voong, K.R., Lee, B., Peterson, V., Feliciano, J.L., Nicholas, L.H., McNutt, T.R., Han, P., Hales, R.K.

Journal:

Annals of Oncology

Year:

2020

Language:

english

File:

PDF, 324 KB

english, 2020

15

Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives

Martinelli, E., Ciardiello, D., Martini, G., Troiani, T., Cardone, C., Vitiello, P.P., Normanno, N., Rachiglio, A.M., Maiello, E., Latiano, T., De Vita, F., Ciardiello, F.

Journal:

Annals of Oncology

Year:

2020

Language:

english

File:

PDF, 531 KB

english, 2020

16

Adverse event profile for immunotherapy agents compared with chemotherapy in solid organ tumors: a systematic review and meta-analysis of randomized clinical trials

Magee, D.E., Hird, A.E., Klaassen, Z., Sridhar, S.S., Nam, R.K., Wallis, C.J.D., Kulkarni, G.S.

Journal:

Annals of Oncology

Year:

2020

Language:

english

File:

PDF, 3.90 MB

english, 2020

17

Chemotherapy-induced peripheral neuropathy: ice, compression, both, or neither?

Loprinzi, C.L., Lustberg, M.B., Hershman, D.L., Ruddy, K.J.

Journal:

Annals of Oncology

Year:

2020

Language:

english

File:

PDF, 154 KB

english, 2020

18

Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Zucca, E., Arcaini, L., Buske, C., Johnson, P.W., Ponzoni, M., Raderer, M., Ricardi, U., Salar, A., Stamatopoulos, K., Thieblemont, C., Wotherspoon, A., Ladetto, M.

Journal:

Annals of Oncology

Year:

2020

Language:

english

File:

PDF, 480 KB

english, 2020

19

Obesity, height, and advanced prostate cancer: extending current evidence toward precision prevention

Dickerman, B.A., Mucci, L.A.

Journal:

Annals of Oncology

Year:

2020

Language:

english

File:

PDF, 148 KB

english, 2020

20

Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges

Heil, J., Kuerer, H.M., Pfob, A., Rauch, G., Sinn, H.P., Golatta, M., Liefers, G.J., Vrancken Peeters, M.J.

Journal:

Annals of Oncology

Year:

2020

Language:

english

File:

PDF, 1.08 MB

english, 2020

21

The challenge of identifying which stage III melanoma patients need adjuvant treatment and with what

Nathan, P.

Journal:

Annals of Oncology

Year:

2020

Language:

english

File:

PDF, 141 KB

english, 2020

22

Electronic symptom monitoring: not everyone fits the mold

Loh, K.P., Mohile, S.G., Flannery, M.

Journal:

Annals of Oncology

Year:

2020

File:

PDF, 151 KB

2020

Volume 31; Issue 1

Should we optimize cytotoxic therapy by dosing to neutropenia? Lessons from TAS-102

Differential effects of an electronic symptom monitoring intervention based on the age of patients with advanced cancer

Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma

Relation of cetuximab-induced skin toxicity and early tumor shrinkage in metastatic colorectal cancer patients: results of the randomized phase 3 trial FIRE-3 (AIO KRK0306)

Man against machine reloaded: performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions

Transferring effective interventions for cancer-related fatigue from the adjuvant to the advanced cancer session: does it work?

Cognitive behavioral therapy or graded exercise therapy compared with usual care for severe fatigue in patients with advanced cancer during treatment: a randomized controlled trial

Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)

Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathy

Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: risk and mortality in The Pooling Project of Prospective Studies of Diet and Cancer

Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAFv600 mutation–positive melanoma receiving adjuvant vemurafenib

Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer

Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials

Financial toxicity in lung cancer: an assessment of magnitude, perception, and impact on quality of life

Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives

Adverse event profile for immunotherapy agents compared with chemotherapy in solid organ tumors: a systematic review and meta-analysis of randomized clinical trials

Chemotherapy-induced peripheral neuropathy: ice, compression, both, or neither?

Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Obesity, height, and advanced prostate cancer: extending current evidence toward precision prevention

Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges

The challenge of identifying which stage III melanoma patients need adjuvant treatment and with what

Table of Contents

Electronic symptom monitoring: not everyone fits the mold